18 results
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
TRANSACTIONS, AND DIRECTOR INDEPENDENCE 81 Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES 81 PART IV Item 15. EXHIBIT AND FINANCIAL STATEMENT SCHEDULES 82 … 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE The information required by this Item is incorporated by reference
PRE 14A
rm5b40 4npahhpozhhg
17 Apr 20
Preliminary proxy
5:13pm
8-K
EX-10.11
7ldq nk1yt
13 Mar 19
X4 Pharmaceuticals Completes Merger with Arsanis
5:28pm
S-4/A
39p44y0
13 Feb 19
Registration of securities issued in business combination transactions (amended)
4:44pm
S-4
a5dtu
20 Dec 18
Registration of securities issued in business combination transactions
5:14pm
10-K
sdkv4do8
9 Mar 18
Annual report
12:00am
- Prev
- 1
- Next